Treatment with RS504393 significantly attenuated hepatic fibrosis, suppressed phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT) pathway activation and reduced M2 macrophage polarization in central lesion tissue of E. multilocularis-infected mice . The gene discussed is AKT1; the disease is Hepatic fibrosis.